Application 021210
- Type
- NDA
- Sponsor
- STEVENS J
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | UNITHROID | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | Yes | No |
| 002 | UNITHROID | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | Yes | No |
| 003 | UNITHROID | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | Yes | No |
| 004 | UNITHROID | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | Yes | No |
| 005 | UNITHROID | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | Yes | No |
| 006 | UNITHROID | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | Yes | No |
| 007 | UNITHROID | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | Yes | No |
| 008 | UNITHROID | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | Yes | No |
| 009 | UNITHROID | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | Yes | No |
| 010 | UNITHROID | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | Yes | No |
| 011 | UNITHROID | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | Yes | Yes |
| 012 | UNITHROID | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021210-001 | UNITHROID | LEVOTHYROXINE SODIUM | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 |
| N021210-002 | UNITHROID | LEVOTHYROXINE SODIUM | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 |
| N021210-003 | UNITHROID | LEVOTHYROXINE SODIUM | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 |
| N021210-004 | UNITHROID | LEVOTHYROXINE SODIUM | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 |
| N021210-005 | UNITHROID | LEVOTHYROXINE SODIUM | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 |
| N021210-006 | UNITHROID | LEVOTHYROXINE SODIUM | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 |
| N021210-007 | UNITHROID | LEVOTHYROXINE SODIUM | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 |
| N021210-008 | UNITHROID | LEVOTHYROXINE SODIUM | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 |
| N021210-009 | UNITHROID | LEVOTHYROXINE SODIUM | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 |
| N021210-010 | UNITHROID | LEVOTHYROXINE SODIUM | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 |
| N021210-011 | UNITHROID | LEVOTHYROXINE SODIUM | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD, RS | 2000-08-21 |
| N021210-012 | UNITHROID | LEVOTHYROXINE SODIUM | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2008-02-08 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N021210-001 | AB1 |
| N021210-001 | AB2 |
| N021210-001 | AB3 |
| N021210-002 | AB1 |
| N021210-002 | AB2 |
| N021210-002 | AB3 |
| N021210-003 | AB1 |
| N021210-003 | AB2 |
| N021210-003 | AB3 |
| N021210-004 | AB1 |
| N021210-004 | AB2 |
| N021210-004 | AB3 |
| N021210-005 | AB1 |
| N021210-005 | AB2 |
| N021210-005 | AB3 |
| N021210-006 | AB1 |
| N021210-006 | AB2 |
| N021210-006 | AB3 |
| N021210-007 | AB1 |
| N021210-007 | AB2 |
| N021210-007 | AB3 |
| N021210-008 | AB1 |
| N021210-008 | AB2 |
| N021210-008 | AB3 |
| N021210-009 | AB1 |
| N021210-009 | AB2 |
| N021210-009 | AB3 |
| N021210-010 | AB1 |
| N021210-010 | AB2 |
| N021210-010 | AB3 |
| N021210-011 | AB1 |
| N021210-011 | AB2 |
| N021210-011 | AB3 |
| N021210-012 | AB1 |
| N021210-012 | AB2 |
| N021210-012 | AB3 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N021210-001 | UNITHROID | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-002 | UNITHROID | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-003 | UNITHROID | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-004 | UNITHROID | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-005 | UNITHROID | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-006 | UNITHROID | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-007 | UNITHROID | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-008 | UNITHROID | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-009 | UNITHROID | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-010 | UNITHROID | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-011 | UNITHROID | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD, RS | 2000-08-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-012 | UNITHROID | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2008-02-08 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021210-001 | UNITHROID | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021210-002 | UNITHROID | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021210-003 | UNITHROID | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021210-004 | UNITHROID | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021210-005 | UNITHROID | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021210-006 | UNITHROID | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021210-007 | UNITHROID | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021210-008 | UNITHROID | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021210-009 | UNITHROID | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021210-010 | UNITHROID | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021210-011 | UNITHROID | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD, RS | 2000-08-21 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021210-012 | UNITHROID | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2008-02-08 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N021210-001 | UNITHROID | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021210-002 | UNITHROID | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021210-003 | UNITHROID | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021210-004 | UNITHROID | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021210-005 | UNITHROID | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021210-006 | UNITHROID | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021210-007 | UNITHROID | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021210-008 | UNITHROID | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021210-009 | UNITHROID | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021210-010 | UNITHROID | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021210-011 | UNITHROID | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD, RS | 2000-08-21 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021210-012 | UNITHROID | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2008-02-08 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021210-001 | UNITHROID | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021210-002 | UNITHROID | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021210-003 | UNITHROID | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021210-004 | UNITHROID | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | fd3edfee7708… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N021210-001 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-001 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-001 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-002 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-002 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-002 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-003 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-003 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-003 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-004 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-004 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-004 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-005 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-005 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-005 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-006 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-006 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-006 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-007 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-007 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-007 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-008 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-008 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-008 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-009 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-009 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-009 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-010 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-010 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-010 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-011 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-011 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-011 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-012 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-012 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-012 | AB3 | 3 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021210-001 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021210-001 | AB2 | 2 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021210-001 | AB3 | 3 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021210-002 | AB1 | 1 | 31067a03dcf5… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | NCS HealthCare of KY, LLC dba Vangard Labs | abe173cc-1579-43a5-b12d-a31958d0a539 | 2026-06-04 | Boxed warning, Warnings, Adverse reactions | 021210 NDA021210 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | c968836a-f94c-4d13-e053-2995a90a8df5 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 021210 NDA021210 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Amneal Pharmaceuticals NY LLC | fca88c97-5cd4-4834-ba87-deb5bd637788 | 2024-12-06 | Boxed warning, Warnings, Adverse reactions | 021210 NDA021210 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 2f0657d5-3e5c-4249-bfaa-7f5ef1528672 | 2021-01-01 | Boxed warning, Warnings, Adverse reactions | 021210 NDA021210 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 97e28b00-9913-463f-9de2-08c828edbe67 | 2020-03-01 | Boxed warning, Warnings, Adverse reactions | 021210 NDA021210 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 05ab038e-45fa-488e-a05e-12a2dd3564c1 | 2020-01-01 | Boxed warning, Warnings, Adverse reactions | 021210 NDA021210 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | b81720f9-2836-4c1d-8691-0f6acef13316 | 2020-01-01 | Boxed warning, Warnings, Adverse reactions | 021210 NDA021210 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 434075d5-a82b-4f17-85e6-4c1922663dbc | 2019-10-01 | Boxed warning, Warnings, Adverse reactions | 021210 NDA021210 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 18c7c63a-642e-47fe-a8ee-12aaf652b2aa | 2019-10-01 | Boxed warning, Warnings, Adverse reactions | 021210 NDA021210 |
| Unithroid | LEVOTHYROXINE SODIUM | Amneal Pharmaceuticals LLC | 07562e72-7eaa-4ce6-94f0-e08814787e50 | 2019-06-19 | Boxed warning, Warnings, Adverse reactions | 021210 NDA021210 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0527-1341 | Levothyroxine Sodium | Levothyroxine Sodium | Lannett Company, Inc. | NDA | Current |
| 0527-1342 | Levothyroxine Sodium | Levothyroxine Sodium | Lannett Company, Inc. | NDA | Current |
| 0527-1343 | Levothyroxine Sodium | Levothyroxine Sodium | Lannett Company, Inc. | NDA | Current |
| 0527-1344 | Levothyroxine Sodium | Levothyroxine Sodium | Lannett Company, Inc. | NDA | Current |
| 0527-1345 | Levothyroxine Sodium | Levothyroxine Sodium | Lannett Company, Inc. | NDA | Current |
| 0527-1346 | Levothyroxine Sodium | Levothyroxine Sodium | Lannett Company, Inc. | NDA | Current |
| 0527-1347 | Levothyroxine Sodium | Levothyroxine Sodium | Lannett Company, Inc. | NDA | Current |
| 0527-1349 | Levothyroxine Sodium | Levothyroxine Sodium | Lannett Company, Inc. | NDA | Current |
| 0527-1350 | Levothyroxine Sodium | Levothyroxine Sodium | Lannett Company, Inc. | NDA | Current |
| 0527-1351 | Levothyroxine Sodium | Levothyroxine Sodium | Lannett Company, Inc. | NDA | Current |
| 0527-1352 | Levothyroxine Sodium | Levothyroxine Sodium | Lannett Company, Inc. | NDA | Current |
| 0527-1370 | UNITHROID | levothyroxine sodium | Lannett Company, Inc. | NDA | Current |
| 0527-1371 | UNITHROID | levothyroxine sodium | Lannett Company, Inc. | NDA | Current |
| 0527-1372 | UNITHROID | levothyroxine sodium | Lannett Company, Inc. | NDA | Current |
| 0527-1373 | UNITHROID | levothyroxine sodium | Lannett Company, Inc. | NDA | Current |
| 0527-1374 | UNITHROID | levothyroxine sodium | Lannett Company, Inc. | NDA | Current |
| 0527-1375 | UNITHROID | levothyroxine sodium | Lannett Company, Inc. | NDA | Current |
| 0527-1376 | UNITHROID | levothyroxine sodium | Lannett Company, Inc. | NDA | Current |
| 0527-1377 | UNITHROID | levothyroxine sodium | Lannett Company, Inc. | NDA | Current |
| 0527-1378 | UNITHROID | levothyroxine sodium | Lannett Company, Inc. | NDA | Current |
| 0527-1379 | UNITHROID | levothyroxine sodium | Lannett Company, Inc. | NDA | Current |
| 0527-1380 | UNITHROID | levothyroxine sodium | Lannett Company, Inc. | NDA | Current |
| 0527-1638 | Levothyroxine Sodium | Levothyroxine Sodium | Lannett Company, Inc. | NDA | Current |
| 0527-1639 | UNITHROID | levothyroxine sodium | Lannett Company, Inc. | NDA | Current |
| 10544-228 | Levothyroxine Sodium | Levothyroxine Sodium | Blenheim Pharmacal, Inc. | NDA | Current |
| 10544-229 | Levothyroxine Sodium | Levothyroxine Sodium | Blenheim Pharmacal, Inc. | NDA | Current |
| 10544-247 | Levothyroxine Sodium | Levothyroxine Sodium | Blenheim Pharmacal, Inc. | NDA | Current |
| 10544-256 | Levothyroxine Sodium | Levothyroxine Sodium | Blenheim Pharmacal, Inc. | NDA | Current |
| 10544-257 | Levothyroxine Sodium | Levothyroxine Sodium | Blenheim Pharmacal, Inc. | NDA | Current |
| 10544-258 | Levothyroxine Sodium | Levothyroxine Sodium | Blenheim Pharmacal, Inc. | NDA | Current |
| 10544-260 | Levothyroxine Sodium | Levothyroxine Sodium | Blenheim Pharmacal, Inc. | NDA | Current |
| 10544-261 | Levothyroxine Sodium | Levothyroxine Sodium | Blenheim Pharmacal, Inc. | NDA | Current |
| 10544-262 | Levothyroxine Sodium | Levothyroxine Sodium | Blenheim Pharmacal, Inc. | NDA | Current |
| 10544-264 | Levothyroxine Sodium | Levothyroxine Sodium | Blenheim Pharmacal, Inc. | NDA | Current |
| 10544-266 | Levothyroxine Sodium | Levothyroxine Sodium | Blenheim Pharmacal, Inc. | NDA | Current |
| 10544-267 | Levothyroxine Sodium | Levothyroxine Sodium | Blenheim Pharmacal, Inc. | NDA | Current |
| 21695-748 | Levothyroxine Sodium | Levothyroxine Sodium | Rebel Distributors Corp. | NDA | Current |
| 21695-749 | Levothyroxine Sodium | Levothyroxine Sodium | Rebel Distributors Corp. | NDA | Current |
| 21695-750 | Levothyroxine Sodium | Levothyroxine Sodium | Rebel Distributors Corp. | NDA | Current |
| 21695-751 | Levothyroxine Sodium | Levothyroxine Sodium | Rebel Distributors Corp | NDA | Current |
| 21695-752 | Levothyroxine Sodium | Levothyroxine Sodium | Rebel Distributors Corp. | NDA | Current |
| 21695-753 | Levothyroxine Sodium | Levothyroxine Sodium | Rebel Distributors Corp | NDA | Current |
| 21695-754 | Levothyroxine Sodium | Levothyroxine Sodium | Rebel Distributors Corp. | NDA | Current |
| 21695-755 | Levothyroxine Sodium | Levothyroxine Sodium | Rebel Distributors Corp | NDA | Current |
| 21695-756 | Levothyroxine Sodium | Levothyroxine Sodium | Rebel Distributors Corp. | NDA | Current |
| 21695-757 | Levothyroxine Sodium | Levothyroxine Sodium | Rebel Distributors Corp | NDA | Current |
| 21695-758 | Levothyroxine Sodium | Levothyroxine Sodium | Rebel Distributors Corp. | NDA | Current |
| 35356-515 | Levothyroxine Sodium | Levothyroxine Sodium | Lake Erie Medical DBA Quality Care Products LLC | NDA | Current |
| 35356-772 | Levothyroxine Sodium | Levothyroxine Sodium | Lake Erie Medical DBA Quality Care Products LLC | NDA | Current |
| 43063-191 | Levothyroxine Sodium | Levothyroxine Sodium | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 43063-420 | Levothyroxine Sodium | Levothyroxine Sodium | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 43063-421 | Levothyroxine Sodium | Levothyroxine Sodium | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 43063-422 | Levothyroxine Sodium | Levothyroxine Sodium | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 43063-475 | Levothyroxine Sodium | Levothyroxine Sodium | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 43063-945 | Levothyroxine Sodium | Levothyroxine Sodium | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 43063-945 | Levothyroxine Sodium | Levothyroxine Sodium | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 43063-945 | Levothyroxine Sodium | Levothyroxine Sodium | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 43063-945 | Levothyroxine Sodium | Levothyroxine Sodium | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 43063-945 | Levothyroxine Sodium | Levothyroxine Sodium | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 43063-948 | Levothyroxine Sodium | Levothyroxine Sodium | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 43063-948 | Levothyroxine Sodium | Levothyroxine Sodium | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 43063-948 | Levothyroxine Sodium | Levothyroxine Sodium | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 43063-948 | Levothyroxine Sodium | Levothyroxine Sodium | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 43063-948 | Levothyroxine Sodium | Levothyroxine Sodium | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 43063-949 | Levothyroxine Sodium | Levothyroxine Sodium | PD-Rx Pharmaceuticals, In | NDA | Current |
| 43063-949 | Levothyroxine Sodium | Levothyroxine Sodium | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 43063-949 | Levothyroxine Sodium | Levothyroxine Sodium | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 43063-949 | Levothyroxine Sodium | Levothyroxine Sodium | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 43063-949 | Levothyroxine Sodium | Levothyroxine Sodium | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 43063-949 | Levothyroxine Sodium | Levothyroxine Sodium | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 43063-950 | Levothyroxine Sodium | Levothyroxine Sodium | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 43063-950 | Levothyroxine Sodium | Levothyroxine Sodium | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 43063-950 | Levothyroxine Sodium | Levothyroxine Sodium | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 43063-950 | Levothyroxine Sodium | Levothyroxine Sodium | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 43063-950 | Levothyroxine Sodium | Levothyroxine Sodium | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 43063-950 | Levothyroxine Sodium | Levothyroxine Sodium | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 43063-951 | Levothyroxine Sodium | Levothyroxine Sodium | PD-Rx Pharmaceuticals, In | NDA | Current |
| 43063-951 | Levothyroxine Sodium | Levothyroxine Sodium | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 43063-951 | Levothyroxine Sodium | Levothyroxine Sodium | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 43063-951 | Levothyroxine Sodium | Levothyroxine Sodium | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 56834 | SUPPL | 2018-12-20 |
| 56720 | SUPPL | 2018-12-12 |
| 21510 | SUPPL | 2011-02-15 |
| 44106 | ORIG | 2009-05-30 |
| 36360 | SUPPL | 2008-02-14 |
| 27077 | SUPPL | 2008-02-14 |
| 21509 | SUPPL | 2005-05-13 |
| 21508 | SUPPL | 2005-05-13 |
| 4644 | SUPPL | 2004-12-22 |
| 27076 | SUPPL | 2004-06-24 |
| 42031 | ORIG | 2000-08-21 |
| 27075 | ORIG | 2000-08-21 |
| 14639 | ORIG | 2000-08-21 |